InvestorsHub Logo
Followers 57
Posts 5698
Boards Moderated 0
Alias Born 12/13/2004

Re: dia76ca post# 1687

Friday, 02/17/2017 10:55:17 AM

Friday, February 17, 2017 10:55:17 AM

Post# of 6035
This bodes well for the 2 year data!

" Researchers reported that HS-410, in combination with BCG, continues to be generally well-tolerated, that HS-410 activates
CD8+ T cells and that these immune responders appear to have a lower recurrence rate than non-immune responders."

"The refusal of the real is the number one dogma of our time" Rene Girard

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NHWK News